| http://www.w3.org/ns/prov#value | - elash enhancer.FDA review finds no major safety issuesNo major safety issues were raised in the FDA review although four patients in the 278-person clinical study left because of side effects such as dry eye and eye inflammation.Allergan said it would minimize risk by telling doctors and patients about potential drug side effects and instructing users not to use Latisse on lower eyelashes.The drug
|
